Cell Therapy Market to Grow with a CAGR of 12.09% Through 2028

Rising Prevalence of Chronic and Genetic Diseases and Increasing Patient Demand for Personalized Medicine are driving Global Cell Therapy Market in the forecast period 2024-2028.

According to TechSci Research report, “Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the Global Cell Therapy Market stood at USD 5.02 Billion in 2022 and is anticipated to project formidable growth in the forecast period with a CAGR of 12.09% through 2028. The cell therapy market has garnered significant attention from investors and venture capitalists due to its immense potential for disrupting traditional healthcare approaches. As clinical trials yield positive results and move toward commercialization, the financial backing of these ventures accelerates market growth. The influx of funds supports research, clinical trials, manufacturing infrastructure, and the development of scalable therapies, further fueling the expansion of the market. The complexity of cell therapies often requires interdisciplinary expertise and collaboration between academic institutions, biotech companies, pharmaceutical giants, and research organizations. Collaborations and partnerships facilitate knowledge exchange, resource sharing, and the development of more comprehensive and effective cell therapies. These synergies drive innovation and foster an environment conducive to market expansion. Chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurodegenerative conditions continue to pose significant challenges to global healthcare systems. Conventional treatment approaches often fall short in delivering effective and long-lasting solutions. Cell therapy, with its potential to regenerate damaged tissues and restore normal cellular functions, offers a promising alternative. As the prevalence of these diseases continues to rise, the demand for innovative therapeutic options drives the growth of the cell therapy market. Moreover, positive clinical outcomes and success stories of patients who have benefited from cell therapies generate immense interest and confidence in these novel treatment approaches. As more success stories emerge, both healthcare professionals and patients become more receptive to exploring cell therapies as viable treatment options. This increased acceptance contributes to the steady growth of the market.

However, the development, manufacturing, and administration of cell therapies can be expensive. Striking a balance between affordability and recouping research and development costs is a delicate task and the manipulation and transplantation of living cells carry inherent risks, including potential immune reactions, infections, and unintended cell behaviors, which may hamper the growth of the market in the projected period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " Global Cell Therapy Market.”

Global Cell Therapy is segmented based on Therapy Type, and Therapeutic Area. Based on Therapy Type, the market is divided into Autologous and Allogenic. The Autologous segment is expected to witness a rise over the forecast period. This is attributed to the fact that Immunotherapy, which includes cell therapies like CAR-T cell therapy, harnesses the body's immune system to recognize and attack cancer cells. This approach has transformed cancer treatment by providing potentially curative options for patients who had limited or no treatment options previously. CAR-T cell therapies, for instance, involve modifying a patient's T cells to recognize and target cancer cells, leading to improved outcomes in certain leukemia and lymphoma cases.

Based on Therapeutic Area, the market is divided into Oncology, Cardiovascular Diseases, Musculoskeletal Disorders and Dermatology. The Oncology segment is expected to witness a rise over the forecast period. This is attributed to the fact that Using a patient's own cells reduces the risk of adverse reactions, making autologous therapies generally safer. Additionally, ethical concerns associated with using cells from donors are eliminated.

Major companies operating in Global Cell Therapy market are:

• Novartis AG
• Gilead Sciences, Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc
• JCR Pharmaceuticals Co., Ltd.
• Tego Science
• Atara Biotherapeutics
• Takeda Pharmaceutical Company Limited
• Bluebird Bio, Inc.
• Dendreon Corp.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

" North America's domination in Cell Therapy reflects its commitment to advancing healthcare through technological innovation, research, and proactive public health initiatives. The prevalence of chronic diseases and aging populations in North America has created a substantial market demand for innovative therapies, including cell-based treatments. The large patient base provides a significant opportunity for cell therapy companies to gain traction and generate revenue. Further, North American cell therapy companies have been proactive in forming collaborations and partnerships with academic institutions, research organizations, hospitals, and other stakeholders. These collaborations facilitate knowledge sharing, access to resources, and a more streamlined approach to development and commercialization and are creating favorable conditions to boost the global demand for Cell Therapy till 2028.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm. 

“Cell Therapy Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Therapy Type (Autologous, Allogenic), By Therapeutic Area (Oncology, Cardiovascular Diseases, Musculoskeletal Disorders, Dermatology), By Region, By Competition., has evaluated the future growth potential of global Cell Therapy and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Cell Therapy market.”

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com